Showing results (961-970 of 1,194) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|July 21, 2018
A Bayesian K-PD model for synergy: A case studyFabiola La Gamba, Tom Jacobs, Helena Geys, et al.Pharmaceutical Statistics|July 10, 2018
A proposal for a new PhD level curriculum on quantitative methods for drug developmentT Jaki, A Gordon, P Forster, et al.Pharmaceutical Statistics|July 22, 2008
A simple two-stage design for quantitative responses with application to a study in diabetic neuropathic painJohn Whitehead, Elsa Valdés-Márquez, Agneta LissmatsPharmaceutical Statistics|September 14, 2007
The impact of missing data and how it is handled on the rate of false-positive results in drug developmentSunni A Barnes, Craig H Mallinckrodt, Stacy R Lindborg, et al.Pharmaceutical Statistics|April 17, 2007
Implementation of an adaptive group sequential design in a bioequivalence studyNibedita Bandyopadhyay, Vladimir DragalinPharmaceutical Statistics|November 28, 2006
Randomization as a basis for inference in noninferiority trialsBrian L WiensPharmaceutical Statistics|September 12, 2007
Conditional approval: discussion points from the PSI conditional approval expert groupKevin Carroll, Hilary Chaudri Ross, Dan Evans, et al.Pharmaceutical Statistics|August 11, 2020
Score and deviance residuals based on the full likelihood approach in survival analysisSusan Halabi, Sandipan Dutta, Yuan Wu, et al.Pharmaceutical Statistics|August 12, 2020
A Bayesian basket trial design accounting for uncertainties of homogeneity and heterogeneity of treatment effect among subpopulationsJunichi Asano, Akihiro HirakawaPharmaceutical Statistics|April 11, 2023
Generalized phase I-II designs to increase long term therapeutic success ratePeter F Thall, Yong Zang, Ying YuanPageof 120